The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025.
Nathan Posner | Anadolu | Getty Images
A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the agency following multiple decisions that raised concerns within the industry.
Vinay Prasad, director of the Center for Biologics Evaluation and Research, will leave the FDA at the end of April, an agency spokesperson confirmed on Friday.
In an interview with the Wall Street Journal, FDA Commissioner Marty Makary said Prasad had only planned to stay in the role for as long as his one-year leave from the University of California at San Francisco, where he taught before taking the FDA role.
— CNBC’s Angelica Peebles contributed to this report
This is breaking news. Please refresh for updates.
Source: www.cnbc.com
